J. Meireles-Brandao: Role of Modifiable Cardiovascular Risk Factors in Dementia Development
J. Meireles-Brandao, Associate at SEDES – Association for Economic and Social Development, shared a post on LinkedIn about a recent article by Jiao Luo et al., published in Atherosclerosis, adding:
“Lipoprotein, LDLc, CVRF, Dementia, CVD
Findings provide causal insights into the role of modifiable cardiovascular risk factors in dementia development and highlight several potentially important targets for dementia prevention.
The results support a potential causal contribution of elevated LDL-C, triglycerides, hypertension, diabetes, smoking, and excess body weight to dementia risk
and may help prioritize risk factors for prevention strategies and future intervention studies to preserve brain health and reduce dementia risk.
Mitigating the consequences of the atherosclerotic process!”
Title: Causal insights of modifiable cardiovascular risk factors for dementia risk – potential for efficient prevention and improved brain health
Authors: Jiao Luoa, Ida Juul Rasmussena, Jesper Qvist Thomassena, Ruth Frikke-Schmidt
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 16, 2026, 00:20Mettine Bos: Reflecting on a Fantastic ISTH 2026 in Paris with Team Leiden
-
Jul 16, 2026, 00:19Pierre Grès: Proud to Present My PhD Research at ISTH 2026
-
Jul 16, 2026, 00:19Francis Couturaud: Leela Breton Presents Promising PE Research at ISTH 2026
-
Jul 16, 2026, 00:18Alisa Wolberg: An Honor to Present the Gualtiero Palareti Memorial Plenary Lecture at ISTH 2026
-
Jul 16, 2026, 00:17Edward Lee Carter: What ISTH 2026 Tells Us About the Next Era of Thrombosis Care
-
Jul 16, 2026, 00:17Marc Carrier: Celebrating 25 Years of the Adult Thrombosis Fellowship Program at ISTH 2026
-
Jul 16, 2026, 00:16Nikolaos Kotsiou: The Privilege of Presenting Our Clinic’s Newest Findings at My 1st ISTH 2026
-
Jul 16, 2026, 00:14Empowering the Next Generation of Bleeding Disorders Leaders – WFH
-
Jul 16, 2026, 00:13Wolfgang Miesbach: VOYAGER1 Highlights the Potential of Oral Inno8 at ISTH 2026